Cationic Lipid Nanoparticles for Versatile Nucleic Acid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing lipid nanoparticle formulations for nucleic acid delivery lack high potency and versatility in administering various types of therapeutic agents, necessitating improved formulations for effective intracellular delivery.
Innovation Solution
Development of novel cationic lipids represented by specific structural formulas, which can be synthesized and incorporated into nanoparticle compositions, enhancing the delivery of nucleic acids such as mRNA, siRNA, and circular RNA for therapeutic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing lipid nanoparticle formulations are used, then nucleic acid delivery is achieved, but high potency and versatility for various therapeutic agents are lacking
Solution Approach 1:
The patent develops a series of cationic lipids with modular structures that can deliver multiple types of nucleic acids including mRNA, siRNA, and circular RNA. The lipids are designed with ionizable amino groups and tunable hydrophobic regions that enable universal binding and delivery across different nucleic acid therapeutics, achieving both high potency and versatility simultaneously
2Productivity
If novel cationic lipids are developed for improved delivery, then intracellular delivery efficiency increases, but formulation complexity increases
Solution Approach 1:
The patent optimizes key parameters of the cationic lipid structure including the ionizable amino group pKa, hydrophobic chain length, and headgroup composition to achieve high delivery efficiency. By systematically tuning these parameters within specific ranges, the patent achieves effective delivery while maintaining formulation simplicity and manufacturability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel cationic lipids facilitate efficient intracellular delivery of therapeutic nucleic acids, enabling the production of polypeptides of interest and treatment of diseases by forming stable lipid nanoparticles.
Implementation Method 1
Lipid nanoparticles (LNPs) formed from cationic lipids and other co-lipids including but not limited to cholesterol, DSPC and PEGylated lipids encapsulated oligonucleotides
Implementation Method 2
Cationic lipids have proved to be excellent carriers of nucleic acids... encapsulated oligonucleotides which protect them from degradation and facilitate the cellular uptake
Data Source
AI summary
The present invention provides cationic lipids and lipid nanoparticle formulations comprising these lipids, alone or in combination with other lipids. These lipid nanoparticles may be formulated with nucleic acids to facilitate their intracellular delivery both in vitro and for therapeutic applications. The present invention also provides methods of chemical synthesis of these lipids.